| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Aidite (Qinhuangdao) Technology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥66.81 |
| 52 Week High | CN¥100.00 |
| 52 Week Low | CN¥66.65 |
| Beta | 0 |
| 11 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -20.48% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| 301580 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | -13.5% | -5.2% | -1.4% |
| 1Y | n/a | -21.1% | -19.1% |
Return vs Industry: Insufficient data to determine how 301580 performed against the CN Medical Equipment industry.
Return vs Market: Insufficient data to determine how 301580 performed against the CN Market.
Price Volatility
| 301580 volatility | |
|---|---|
| 301580 Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 6.1% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in CN Market | 10.0% |
| 10% least volatile stocks in CN Market | 4.2% |
Stable Share Price: 301580's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 301580's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | n/a | n/a | www.aidite.com |
Aidite (Qinhuangdao) Technology Co., Ltd. research and development of zirconia materials, dental materials, related consumables, and equipment for dental industry in China. It offers ceramic denture zirconia repair materials, zirconia treatment agents, dental grinding and polishing burs, and dental five-axis cutting machines The company was incorporated in 2007 and is based in Qinhuangdao, China.
Aidite (Qinhuangdao) Technology Co., Ltd. Fundamentals Summary
| 301580 fundamental statistics | |
|---|---|
| Market cap | CN¥5.09b |
| Earnings (TTM) | CN¥153.70m |
| Revenue (TTM) | CN¥808.03m |
33.1x
P/E Ratio6.3x
P/S RatioIs 301580 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 301580 income statement (TTM) | |
|---|---|
| Revenue | CN¥808.03m |
| Cost of Revenue | CN¥403.71m |
| Gross Profit | CN¥404.32m |
| Other Expenses | CN¥250.61m |
| Earnings | CN¥153.70m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.02 |
| Gross Margin | 50.04% |
| Net Profit Margin | 19.02% |
| Debt/Equity Ratio | 0.04% |
How did 301580 perform over the long term?
See historical performance and comparison